Late endophthalmitis associated with glaucoma drainage implants

Steven J Gedde, Ingrid U. Scott, Homayoun Tabandeh, Kevin K M Luu, Donald L. Budenz, David Greenfield, Harry W Flynn

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

Objective: To report the clinical course of a series of patients who had late endophthalmitis develop after glaucoma drainage implant (GDI) surgery. Design: Noncomparative, interventional, consecutive case series. Participants: Four patients were identified with late endophthalmitis associated with Baerveldt glaucoma implants. Methods: The medical records of all patients with endophthalmitis associated with a GDI treated at the Bascom Palmer Eye Institute or University of Florida between January 1, 1987 and December 31, 1999 were retrospectively reviewed. Patients with culture-positive endophthalmitis diagnosed more than 1 month after GDI surgery were included in this series. Main Outcome Measures: Visual acuity and intraocular pressure (IOP). Results: Late endophthalmitis associated with Baerveldt glaucoma implants developed 7 weeks to 2 years postoperatively. Exposure of the GDI tube was present in all cases. The implant was removed in three of four patients. Visual acuity worsened from preinfection level in two of four cases. IOP was controlled at last follow-up in all patients, although replacement of the explanted GDI was required in one patient. Conclusions: Late endophthalmitis may occur after GDI surgery. Exposure of the GDI tube seems to represent a major risk factor for these infections. To prevent this potentially devastating complication, we recommend prophylactic surgical revision with a patch graft in all cases in which there is an exposed GDI tube.

Original languageEnglish
Pages (from-to)1323-1327
Number of pages5
JournalOphthalmology
Volume108
Issue number7
DOIs
StatePublished - Jul 4 2001

Fingerprint

Glaucoma Drainage Implants
Endophthalmitis
Intraocular Pressure
Glaucoma
Visual Acuity
Reoperation
Medical Records

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Late endophthalmitis associated with glaucoma drainage implants. / Gedde, Steven J; Scott, Ingrid U.; Tabandeh, Homayoun; Luu, Kevin K M; Budenz, Donald L.; Greenfield, David; Flynn, Harry W.

In: Ophthalmology, Vol. 108, No. 7, 04.07.2001, p. 1323-1327.

Research output: Contribution to journalArticle

Gedde, Steven J ; Scott, Ingrid U. ; Tabandeh, Homayoun ; Luu, Kevin K M ; Budenz, Donald L. ; Greenfield, David ; Flynn, Harry W. / Late endophthalmitis associated with glaucoma drainage implants. In: Ophthalmology. 2001 ; Vol. 108, No. 7. pp. 1323-1327.
@article{d58c812e8d5840a0bba68cc6ace4a21c,
title = "Late endophthalmitis associated with glaucoma drainage implants",
abstract = "Objective: To report the clinical course of a series of patients who had late endophthalmitis develop after glaucoma drainage implant (GDI) surgery. Design: Noncomparative, interventional, consecutive case series. Participants: Four patients were identified with late endophthalmitis associated with Baerveldt glaucoma implants. Methods: The medical records of all patients with endophthalmitis associated with a GDI treated at the Bascom Palmer Eye Institute or University of Florida between January 1, 1987 and December 31, 1999 were retrospectively reviewed. Patients with culture-positive endophthalmitis diagnosed more than 1 month after GDI surgery were included in this series. Main Outcome Measures: Visual acuity and intraocular pressure (IOP). Results: Late endophthalmitis associated with Baerveldt glaucoma implants developed 7 weeks to 2 years postoperatively. Exposure of the GDI tube was present in all cases. The implant was removed in three of four patients. Visual acuity worsened from preinfection level in two of four cases. IOP was controlled at last follow-up in all patients, although replacement of the explanted GDI was required in one patient. Conclusions: Late endophthalmitis may occur after GDI surgery. Exposure of the GDI tube seems to represent a major risk factor for these infections. To prevent this potentially devastating complication, we recommend prophylactic surgical revision with a patch graft in all cases in which there is an exposed GDI tube.",
author = "Gedde, {Steven J} and Scott, {Ingrid U.} and Homayoun Tabandeh and Luu, {Kevin K M} and Budenz, {Donald L.} and David Greenfield and Flynn, {Harry W}",
year = "2001",
month = "7",
day = "4",
doi = "10.1016/S0161-6420(01)00598-X",
language = "English",
volume = "108",
pages = "1323--1327",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Late endophthalmitis associated with glaucoma drainage implants

AU - Gedde, Steven J

AU - Scott, Ingrid U.

AU - Tabandeh, Homayoun

AU - Luu, Kevin K M

AU - Budenz, Donald L.

AU - Greenfield, David

AU - Flynn, Harry W

PY - 2001/7/4

Y1 - 2001/7/4

N2 - Objective: To report the clinical course of a series of patients who had late endophthalmitis develop after glaucoma drainage implant (GDI) surgery. Design: Noncomparative, interventional, consecutive case series. Participants: Four patients were identified with late endophthalmitis associated with Baerveldt glaucoma implants. Methods: The medical records of all patients with endophthalmitis associated with a GDI treated at the Bascom Palmer Eye Institute or University of Florida between January 1, 1987 and December 31, 1999 were retrospectively reviewed. Patients with culture-positive endophthalmitis diagnosed more than 1 month after GDI surgery were included in this series. Main Outcome Measures: Visual acuity and intraocular pressure (IOP). Results: Late endophthalmitis associated with Baerveldt glaucoma implants developed 7 weeks to 2 years postoperatively. Exposure of the GDI tube was present in all cases. The implant was removed in three of four patients. Visual acuity worsened from preinfection level in two of four cases. IOP was controlled at last follow-up in all patients, although replacement of the explanted GDI was required in one patient. Conclusions: Late endophthalmitis may occur after GDI surgery. Exposure of the GDI tube seems to represent a major risk factor for these infections. To prevent this potentially devastating complication, we recommend prophylactic surgical revision with a patch graft in all cases in which there is an exposed GDI tube.

AB - Objective: To report the clinical course of a series of patients who had late endophthalmitis develop after glaucoma drainage implant (GDI) surgery. Design: Noncomparative, interventional, consecutive case series. Participants: Four patients were identified with late endophthalmitis associated with Baerveldt glaucoma implants. Methods: The medical records of all patients with endophthalmitis associated with a GDI treated at the Bascom Palmer Eye Institute or University of Florida between January 1, 1987 and December 31, 1999 were retrospectively reviewed. Patients with culture-positive endophthalmitis diagnosed more than 1 month after GDI surgery were included in this series. Main Outcome Measures: Visual acuity and intraocular pressure (IOP). Results: Late endophthalmitis associated with Baerveldt glaucoma implants developed 7 weeks to 2 years postoperatively. Exposure of the GDI tube was present in all cases. The implant was removed in three of four patients. Visual acuity worsened from preinfection level in two of four cases. IOP was controlled at last follow-up in all patients, although replacement of the explanted GDI was required in one patient. Conclusions: Late endophthalmitis may occur after GDI surgery. Exposure of the GDI tube seems to represent a major risk factor for these infections. To prevent this potentially devastating complication, we recommend prophylactic surgical revision with a patch graft in all cases in which there is an exposed GDI tube.

UR - http://www.scopus.com/inward/record.url?scp=0034967765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034967765&partnerID=8YFLogxK

U2 - 10.1016/S0161-6420(01)00598-X

DO - 10.1016/S0161-6420(01)00598-X

M3 - Article

C2 - 11425695

AN - SCOPUS:0034967765

VL - 108

SP - 1323

EP - 1327

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 7

ER -